All guns blazing therapy. Must have a lot of confidence in the side effect profile. So is that Efti with Pembo (anti PD-1) and ??? Paclitaxel???. IMM is familiar with all of these?
Paclitaxel has been used with efti in AIPAC, and EOS in China.
Is this a treatment to piggyback off the success of the following treatments, but in solid tumours?:
https://www.fda.gov/drugs/resources...therapy-first-line-treatment-metastatic-nsclc
https://www.fda.gov/drugs/resources...ves-pembrolizumab-esophageal-or-gej-carcinoma
If the efti triple combo can get better results than the above two trials, they will be able to do another crap raise at a far higher SP - lol
Does anybody know of any solid tumour trials that are more comparable than the above two?
- Forums
- ASX - By Stock
- IMM
- Ann: Efti to be evaluated in new triple combination therapy trial
Ann: Efti to be evaluated in new triple combination therapy trial, page-4
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $450.9M |
Open | High | Low | Value | Volume |
29.0¢ | 31.5¢ | 29.0¢ | $1.805M | 5.903M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 193400 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 193400 | 0.305 |
4 | 51236 | 0.300 |
2 | 49237 | 0.295 |
3 | 66656 | 0.290 |
4 | 118595 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 199990 | 9 |
0.325 | 271463 | 4 |
0.330 | 111100 | 3 |
0.335 | 159207 | 4 |
0.340 | 150000 | 3 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online